XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Oct 1, 2023 | (Q2)Jul 2, 2023 | (Q1)Apr 2, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -18.86%3.29B | -18.86%3.29B | -23.71%2.91B | -21.87%3.02B | -21.48%3.09B | 12.13%4.06B | 12.13%4.06B | 1.54%3.82B | 8.97%3.86B | --3.93B |
-Cash and cash equivalents | -9.76%3.29B | -9.76%3.29B | -34.19%2.51B | -32.23%2.62B | -31.65%2.69B | 0.83%3.65B | 0.83%3.65B | 1.54%3.82B | 8.97%3.86B | --3.93B |
-Short-term investments | --0 | --0 | --400M | --400M | --400M | --409M | --409M | ---- | ---- | ---- |
Receivables | 15.44%1.03B | 15.44%1.03B | 13.95%1.07B | -12.63%927M | -17.12%881M | -6.88%894M | -6.88%894M | -7.21%939M | 6.53%1.06B | --1.06B |
-Accounts receivable | 15.44%1.03B | 15.44%1.03B | 13.95%1.07B | -12.63%927M | -17.12%881M | -6.88%894M | -6.88%894M | -7.21%939M | 6.53%1.06B | --1.06B |
Inventory | 10.40%2.36B | 10.40%2.36B | 4.39%2.23B | 1.95%2.15B | 6.32%2.1B | 19.75%2.13B | 19.75%2.13B | 35.36%2.14B | 44.12%2.11B | --1.98B |
Restricted cash | ---- | ---- | 4.89%236M | --241M | --222M | -5.73%214M | -5.73%214M | --225M | ---- | ---- |
Other current assets | 10.62%625M | 10.62%625M | 15.96%574M | 31.25%546M | 55.81%603M | 62.36%565M | 62.36%565M | 41.03%495M | 31.23%416M | --387M |
Total current assets | -7.11%7.31B | -7.11%7.31B | -7.75%7.03B | -7.61%6.88B | -6.29%6.89B | 13.40%7.86B | 13.40%7.86B | 13.62%7.62B | 17.83%7.45B | --7.36B |
Non current assets | ||||||||||
Net PPE | -1.69%3.27B | -1.69%3.27B | 3.50%3.31B | 4.35%3.29B | 5.80%3.3B | 7.02%3.32B | 7.02%3.32B | 7.61%3.2B | 8.17%3.15B | --3.12B |
-Gross PPE | ---- | ---- | 7.14%9.35B | 7.52%9.19B | 7.25%9.09B | 7.98%8.98B | 7.98%8.98B | 8.67%8.72B | 8.96%8.55B | --8.47B |
-Accumulated depreciation | ---- | ---- | -9.25%-6.04B | -9.38%-5.9B | -8.09%-5.78B | -8.55%-5.66B | -8.55%-5.66B | -9.30%-5.53B | -9.43%-5.4B | ---5.35B |
Goodwill and other intangible assets | -1.02%10.77B | -1.02%10.77B | -2.32%10.69B | -2.92%10.74B | -3.34%10.78B | -3.35%10.88B | -3.35%10.88B | -3.35%10.95B | -3.47%11.06B | --11.16B |
-Goodwill | -0.25%9.93B | -0.25%9.93B | 0.21%9.96B | -0.09%9.94B | -0.04%9.95B | 0.12%9.96B | 0.12%9.96B | 0.28%9.94B | 0.20%9.95B | --9.95B |
-Other intangible assets | -9.33%836M | -9.33%836M | -27.23%735M | -28.29%796M | -30.55%839M | -29.67%922M | -29.67%922M | -28.72%1.01B | -27.31%1.11B | --1.21B |
Non current deferred assets | --1.25B | --1.25B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non current assets | -21.54%1.8B | -21.54%1.8B | 18.11%2.64B | 7.21%2.29B | 11.60%2.34B | 17.87%2.29B | 17.87%2.29B | 15.26%2.24B | 15.58%2.14B | --2.1B |
Total non current assets | 3.58%17.08B | 3.58%17.08B | 1.61%16.64B | -0.20%16.32B | 0.31%16.43B | 1.15%16.49B | 1.15%16.49B | 0.88%16.38B | 0.80%16.35B | --16.38B |
Total assets | 0.13%24.39B | 0.13%24.39B | -1.36%23.67B | -2.52%23.2B | -1.74%23.32B | 4.81%24.35B | 4.81%24.35B | 4.60%24B | 5.57%23.8B | --23.73B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -36.24%1.02B | -36.24%1.02B | -7.89%1.3B | -5.76%1.31B | -4.16%1.38B | -6.18%1.6B | -6.18%1.6B | -29.19%1.41B | -23.54%1.39B | --1.44B |
-accounts payable | -12.63%1.02B | -12.63%1.02B | -6.26%899M | -3.93%929M | -4.79%954M | -1.77%1.16B | -1.77%1.16B | -37.48%959M | -33.86%967M | --1B |
-Total tax payable | ---- | ---- | -25.67%139M | -23.75%122M | -5.08%168M | -42.57%170M | -42.57%170M | -19.40%187M | 19.40%160M | --177M |
-Dividends payable | ---- | ---- | -1.15%258M | -1.52%259M | -1.14%260M | 19.18%261M | 19.18%261M | 18.10%261M | 18.47%263M | --263M |
Current debt and capital lease obligation | -50.00%500M | -50.00%500M | -50.05%499M | -50.05%499M | ---- | --1B | --1B | --999M | --999M | --998M |
-Current debt | -50.00%500M | -50.00%500M | -50.05%499M | -50.05%499M | ---- | --1B | --1B | --999M | --999M | --998M |
Other current liabilities | 55.61%1.58B | 55.61%1.58B | -27.75%781M | -28.26%901M | -18.56%1.04B | -7.89%1.02B | -7.89%1.02B | 49.31%1.08B | 90.30%1.26B | --1.28B |
Current liabilities | -24.64%3.1B | -24.64%3.1B | -24.52%2.99B | -23.82%3.11B | -30.50%2.93B | 25.72%4.11B | 25.72%4.11B | 23.14%3.96B | 38.90%4.09B | --4.21B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 1.76%10.35B | 1.76%10.35B | -4.82%9.68B | -4.82%9.68B | 0.09%10.18B | -8.87%10.18B | -8.87%10.18B | -8.86%10.17B | -8.86%10.17B | --10.17B |
-Long term debt | 1.76%10.35B | 1.76%10.35B | -4.82%9.68B | -4.82%9.68B | 0.09%10.18B | -8.87%10.18B | -8.87%10.18B | -8.86%10.17B | -8.86%10.17B | --10.17B |
Non current deferred liabilities | ---- | ---- | 29.55%57M | 20.00%48M | 21.05%46M | -2.22%44M | -2.22%44M | 12.82%44M | -2.44%40M | --38M |
Other non current liabilities | 31.89%1.4B | 31.89%1.4B | 17.31%1.19B | -1.17%1.01B | -4.32%1.02B | 4.63%1.06B | 4.63%1.06B | -10.40%1.02B | -12.72%1.02B | --1.06B |
Total non current liabilities | 4.20%11.76B | 4.20%11.76B | -2.68%10.93B | -4.40%10.74B | -0.26%11.24B | -7.72%11.28B | -7.72%11.28B | -8.93%11.23B | -9.21%11.23B | --11.27B |
Total liabilities | -3.50%14.85B | -3.50%14.85B | -8.38%13.93B | -9.58%13.85B | -8.49%14.17B | -0.66%15.39B | -0.66%15.39B | -2.30%15.2B | 0.03%15.32B | --15.48B |
Shareholders'equity | ||||||||||
Share capital | ---- | ---- | 0.00%56M | 0.00%56M | 0.00%56M | 0.00%56M | 0.00%56M | 0.00%56M | 0.00%56M | --56M |
-common stock | ---- | ---- | 0.00%56M | 0.00%56M | 0.00%56M | 0.00%56M | 0.00%56M | 0.00%56M | 0.00%56M | --56M |
Retained earnings | ---- | ---- | 41.94%-1.58B | 36.93%-2.04B | 33.71%-2.42B | 29.74%-2.79B | 29.74%-2.79B | 32.53%-2.73B | 28.62%-3.23B | ---3.65B |
Paid-in capital | ---- | ---- | 3.13%14.85B | 3.07%14.73B | 3.01%14.62B | 2.91%14.5B | 2.91%14.5B | 2.87%14.4B | 2.78%14.29B | --14.19B |
Less: Treasury stock | ---- | ---- | 22.55%4.02B | 23.99%3.76B | 26.38%3.47B | 14.68%3.21B | 14.68%3.21B | 18.66%3.28B | 25.17%3.03B | --2.75B |
Gains losses not affecting retained earnings | ---- | ---- | 160.00%104M | -65.52%30M | -55.10%44M | 18.42%90M | 18.42%90M | 128.17%40M | 267.31%87M | --98M |
Total stockholders'equity | 6.24%9.18B | 6.24%9.18B | 10.82%9.41B | 10.35%9.02B | 11.07%8.83B | 16.04%8.64B | 16.04%8.64B | 19.45%8.49B | 17.38%8.17B | --7.95B |
Noncontrolling interests | 10.13%348M | 10.13%348M | 9.03%338M | 7.21%327M | 7.36%321M | 8.59%316M | 8.59%316M | 11.11%310M | 15.53%305M | --299M |
Total equity | 6.37%9.53B | 6.37%9.53B | 10.75%9.74B | 10.24%9.35B | 10.94%9.15B | 15.76%8.96B | 15.76%8.96B | 19.13%8.8B | 17.31%8.48B | --8.25B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |